Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
type: MedicalStudy
description: Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer
status: WITHDRAWN
study design: OBSERVATIONAL
start date: 2023-12-30
end date: 2024-06-30
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05356585
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Case Comprehensive Cancer Center
study subject: Colorectal Cancer
study subject: Rectal Cancer
keywords: OBSERVATIONAL
keywords: WITHDRAWN
keywords: Colorectal Cancer
keywords: Rectal Cancer

AI Analytics
type: Organization